Published 1 month ago

iBio Announces $15.0 Million Private Placement - iBio (AMEX:IBIO)

Summary by Ground News

iBio, Inc. has entered into a securities purchase agreement for a private investment in public equity financing. The Company intends to use the net proceeds from the offering for general corporate purposes, including research and development and working capital. The shares of common stock underlying the pre-funded warrants and warrants have not been registered under the Act or applicable state securities laws.

0 Articles

All

Left

Center

Right

Benzinga

iBio Announces $15.0 Million Private Placement - iBio (AMEX:IBIO)

– Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), an AI-driven innovator of precision antibody immunotherapies, announces today that it has entered into a securities purchase agreement for a private investment in public equity ("PIPE") financing that is expected to result in gross proceeds to the Company of ap…

1 month ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.